Finance
Banking, Economy & Business
Latest Articles (10000)
Novo's CEO Called Ozempic's Patent Cliff the "Elephant in the Room" Yesterday. Is the Stock Still a Buy?
Financial conditions are tightening. Here’s why stock investors should pay attention.
Widening credit spreads worldwide are a sign that how stocks are valued may be changing for the worse.
Betterware Remains A Buy On Insider Buying And LatAm Expansion
How Is Workday’s Stock Performance Compared to Other Software Stocks
Basic Materials Sector Still Shows Promise In 2026, But Proceed With Caution
History Says This Low-Cost Investment Could Outperform Anthropic -- and You Might Already Own It
Viking Therapeutics: The Market Might Shrug Off The Maintenance Data
Netflix Stock Valuations Seem Attractive Amidst Growth Deceleration Concerns
Jim Cramer Prefers Brinker (EAT) Over Darden (DRI) Ahead of Earnings
Bitcoin and ethereum prices today, Tuesday, September 22, 2026: Crypto prices continue to surge to prices last seen in January
Some offers on this page are from advertisers who pay us, which may affect which products we write about, but not our recommendations. See our Advertiser Disclosure . Bitcoin and ethereum prices today...
Yardbird Southern Table & Bar Files for Bankruptcy
Grab Stock Is Worth the Risk as Valuations Fall to Historical Lows
Oil and gas PE deals tumble as new platform buyouts dry up
Binance Takes $100M Stake in Circle Under Five-Year USDC Promotion Deal
Saudi Arabia restarts East-West oil pipeline, sources say
Policy shifts damage retirement planning and UK investment, sector warns
GameStop CEO Ryan Cohen buys $26.4 million of GME stock
Viking Therapeutics Skyrockets On Obesity Drug Data. Eli Lilly, Novo Fall.
Viking Therapeutics and Roche both reported positive trial data on their obesity treatments. Shares of Viking Therapeutics surged in premarket trading while the U.S. shares of Swiss drug giant Roche w...